JP2008230994A - Cosmetic - Google Patents
Cosmetic Download PDFInfo
- Publication number
- JP2008230994A JP2008230994A JP2007070025A JP2007070025A JP2008230994A JP 2008230994 A JP2008230994 A JP 2008230994A JP 2007070025 A JP2007070025 A JP 2007070025A JP 2007070025 A JP2007070025 A JP 2007070025A JP 2008230994 A JP2008230994 A JP 2008230994A
- Authority
- JP
- Japan
- Prior art keywords
- gel
- cosmetic
- acid
- gellan gum
- methoxysalicylate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 40
- 239000000203 mixture Substances 0.000 claims abstract description 26
- MRIXVKKOHPQOFK-UHFFFAOYSA-N 4-methoxysalicylic acid Chemical class COC1=CC=C(C(O)=O)C(O)=C1 MRIXVKKOHPQOFK-UHFFFAOYSA-N 0.000 claims abstract description 19
- 238000004519 manufacturing process Methods 0.000 claims abstract description 14
- 239000000499 gel Substances 0.000 claims description 39
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 108010010803 Gelatin Proteins 0.000 claims 2
- 239000008273 gelatin Substances 0.000 claims 2
- 229920000159 gelatin Polymers 0.000 claims 2
- 235000019322 gelatine Nutrition 0.000 claims 2
- 235000011852 gelatine desserts Nutrition 0.000 claims 2
- 229920002148 Gellan gum Polymers 0.000 abstract description 26
- 239000000216 gellan gum Substances 0.000 abstract description 26
- 235000010492 gellan gum Nutrition 0.000 abstract description 26
- 238000001816 cooling Methods 0.000 abstract 1
- 230000002087 whitening effect Effects 0.000 description 17
- 239000000284 extract Substances 0.000 description 16
- 239000012071 phase Substances 0.000 description 15
- -1 alkaline earth metal cations Chemical class 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- YRJKYHIIYRGTCC-UHFFFAOYSA-M potassium;2-hydroxy-4-methoxybenzoate Chemical compound [K+].COC1=CC=C(C([O-])=O)C(O)=C1 YRJKYHIIYRGTCC-UHFFFAOYSA-M 0.000 description 11
- 239000008213 purified water Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 10
- 238000011156 evaluation Methods 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 8
- 239000008346 aqueous phase Substances 0.000 description 8
- 239000006210 lotion Substances 0.000 description 7
- 239000003205 fragrance Substances 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 229940058015 1,3-butylene glycol Drugs 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 5
- 235000019437 butane-1,3-diol Nutrition 0.000 description 5
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- RJURRZFUWSRXDY-UHFFFAOYSA-N 1-phenoxyethanol Chemical compound CC(O)OC1=CC=CC=C1.CC(O)OC1=CC=CC=C1 RJURRZFUWSRXDY-UHFFFAOYSA-N 0.000 description 4
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 239000004745 nonwoven fabric Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 3
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 3
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 3
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 229940097043 glucuronic acid Drugs 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 235000011118 potassium hydroxide Nutrition 0.000 description 3
- 229960001860 salicylate Drugs 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- 240000006891 Artemisia vulgaris Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 241000736199 Paeonia Species 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- 241000218657 Picea Species 0.000 description 2
- 244000288377 Saxifraga stolonifera Species 0.000 description 2
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 2
- 235000007303 Thymus vulgaris Nutrition 0.000 description 2
- 240000002657 Thymus vulgaris Species 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 239000001585 thymus vulgaris Substances 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- IZZIWIAOVZOBLF-UHFFFAOYSA-N 5-methyloxysalicylic acid Natural products COC1=CC=C(O)C(C(O)=O)=C1 IZZIWIAOVZOBLF-UHFFFAOYSA-N 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 235000003826 Artemisia Nutrition 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 240000004355 Borago officinalis Species 0.000 description 1
- 235000007689 Borago officinalis Nutrition 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 241000422842 Chamaecyparis pisifera Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 241000283070 Equus zebra Species 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 240000000731 Fagus sylvatica Species 0.000 description 1
- 235000010099 Fagus sylvatica Nutrition 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 241000596467 Ononis Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- KYWSCMDFVARMPN-LCSVLAELSA-N Saikosaponin D Chemical compound O([C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@]([C@H]3[C@]([C@@H]4[C@@]([C@@]5(C[C@@H](O)[C@]67CO[C@]5([C@@H]6CC(C)(C)CC7)C=C4)C)(C)CC3)(C)CC2)(C)CO)O[C@@H]([C@@H]1O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KYWSCMDFVARMPN-LCSVLAELSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- LDDUCKDUDZVHLN-UHFFFAOYSA-N [2-hydroxy-3-[2-hydroxy-3-(16-methylheptadecanoyloxy)propoxy]propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)COC(=O)CCCCCCCCCCCCCCC(C)C LDDUCKDUDZVHLN-UHFFFAOYSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 235000009052 artemisia Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229940002508 ginger extract Drugs 0.000 description 1
- 235000020708 ginger extract Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Natural products OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- WPEXVRDUEAJUGY-UHFFFAOYSA-B hexacalcium;(2,3,4,5,6-pentaphosphonatooxycyclohexyl) phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])(=O)OC1C(OP([O-])([O-])=O)C(OP([O-])([O-])=O)C(OP([O-])([O-])=O)C(OP([O-])([O-])=O)C1OP([O-])([O-])=O WPEXVRDUEAJUGY-UHFFFAOYSA-B 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000012943 hotmelt Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940023750 peg-60 glyceryl isostearate Drugs 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 235000008729 phenylalanine Nutrition 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229930192014 saikosaponin Natural products 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 235000008521 threonine Nutrition 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 235000002374 tyrosine Nutrition 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000014393 valine Nutrition 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、ゲルを粉砕した微小ゲル状組成物を配合する化粧料に関する。より詳細には、ジェランガムと、4−メトキシサリチル酸塩を、高温で溶解した後、冷却してゲルを生成させ、該ゲルを粉砕した微小ゲル状組成物を配合する化粧料に関する。また、該化粧料の製造方法に関する。 The present invention relates to a cosmetic containing a fine gel composition obtained by pulverizing a gel. More specifically, the present invention relates to a cosmetic composition in which gellan gum and 4-methoxysalicylate are dissolved at a high temperature and then cooled to form a gel, and a fine gel composition obtained by pulverizing the gel is blended. Moreover, it is related with the manufacturing method of this cosmetics.
化粧料に用いられる美白薬剤には、ビタミンC誘導体やアルブチン、4−メトキシサリチル酸塩などがある。中でも、4−メトキシサリチル酸塩では、高い美白効果が期待される薬剤である。しかしながら、4−メトキシサリチル酸塩を配合すると、ゲルの粘度が低下してしまい、適度な粘度のある化粧料を調製することが困難であった。増粘剤を増量することで適度な粘度のものを調製できる可能性があるが、増粘剤を増量すると、従来のみずみずしく、べたつかない感触を損なうという欠点がある。 Whitening agents used in cosmetics include vitamin C derivatives, arbutin, 4-methoxysalicylate, and the like. Among these, 4-methoxysalicylate is a drug expected to have a high whitening effect. However, when 4-methoxy salicylate is blended, the viscosity of the gel is lowered, and it is difficult to prepare a cosmetic material having an appropriate viscosity. There is a possibility that an agent having an appropriate viscosity can be prepared by increasing the amount of the thickener. However, when the amount of the thickener is increased, there is a drawback that the conventional feeling is not fresh and sticky.
化粧料を評価する上での重要な要素として、使用感触と安定性とが挙げられる。ジェランガムは、その独特の使用感触と電解質添加条件下にも増粘作用を示すという利点から、外用組成物に適用する試みがなされている。近年ではナトリウムやカルシウムなどのアルカリ金属又はアルカリ土類金属の陽イオンを添加してジェランガムをゲル化させたゲルを粉砕して微小ゲルを調製し、増粘外用組成物に適用する検討が成されている(特許文献1参照)。
また、ジェランガムとアンモニウムイオンを放出する電解質を配合する、ゲル状組成物が検討されている。(特許文献2参照)
しかしながら、ジェランガムを用いて増粘した処方系に4−メトキシサリチル酸塩を単純に配合すると、ゲルの粘度が低下し、適度に増粘した化粧料を調整することができなかった。
Further, a gel composition containing gellan gum and an electrolyte that releases ammonium ions has been studied. (See Patent Document 2)
However, when 4-methoxysalicylate is simply blended in a prescription system thickened using gellan gum, the viscosity of the gel is lowered, and it is not possible to prepare a cosmetic material that is moderately thickened.
本発明は、4−メトキシサリチル酸塩を配合し、適度に増粘した化粧料を提供することを技術的課題とする。また、該化粧料の製造方法を提供することを技術的課題とする。 This invention makes it a technical subject to mix | blend 4-methoxy salicylate and to provide the cosmetics moderately thickened. Moreover, let it be a technical subject to provide the manufacturing method of this cosmetics.
本発明者らは前記従来の問題点を解決すべく鋭意研究をした結果、ジェランガムと、4−メトキシサリチル酸塩を、高温で溶解した後、冷却してゲルを生成させ、該ゲルを粉砕した微小ゲル状組成物を化粧料に配合することによって、適度に増粘した化粧料が得られることを見出し、本発明を完成するに至った。 As a result of diligent research to solve the conventional problems, the present inventors dissolved gellan gum and 4-methoxysalicylate at a high temperature, then cooled to produce a gel, and the gel was pulverized. It has been found that a cosmetic composition having a moderately thickened viscosity can be obtained by blending the gel composition into the cosmetic composition, and the present invention has been completed.
すなわち本発明は、ジェランガムと、4−メトキシサリチル酸塩を、80〜95℃で溶解した後、ゲルを形成する温度以下に冷却してゲルを生成させ、該ゲルを粉砕した微小ゲル状組成物を配合することを特徴とする化粧料に関する。
また本発明は、ジェランガムと、4−メトキシサリチル酸塩を、80〜95℃で溶解した後、ゲルを形成する温度以下に冷却してゲルを生成させ、該ゲルを粉砕した微小ゲル状組成物を配合することを特徴とする化粧料の製造方法に関する。
That is, in the present invention, gellan gum and 4-methoxysalicylate are dissolved at 80 to 95 ° C. and then cooled to a temperature below the temperature at which the gel is formed to produce a gel. It is related with the cosmetics characterized by mix | blending.
In the present invention, gellan gum and 4-methoxysalicylate are dissolved at 80 to 95 ° C., and then cooled to a temperature below the temperature at which the gel is formed to produce a gel. It is related with the manufacturing method of the cosmetics characterized by mix | blending.
本発明によれば、ジェランガムと、4−メトキシサリチル酸塩を、高温で溶解した後、冷却してゲルを生成させ、該ゲルを粉砕した微小ゲル状組成物を化粧料に配合することにより、適度に増粘した化粧料を提供できる。 According to the present invention, gellan gum and 4-methoxysalicylate are dissolved at a high temperature, cooled to form a gel, and a fine gel composition obtained by pulverizing the gel is blended into a cosmetic. A thickened cosmetic can be provided.
以下、本発明の好適な実施形態について詳述する。
本発明におけるジェランガムは、U.S.A.のケルコ社が開発したものであり、グルコースを主成分とする培地中でシュードモナス エロデア(Pseudomonas Elodea)が産出する、グルコース、グルクロン酸及びラムノースからなる(グルコース:グルクロン酸:ラムノース=2:1:1の割合)、ヘテロ多糖類を主成分とするものである。また、その分子量は670,000〜920,000程度のものであり、工業的には完全な製造管理下で生産される純度の高い工業製品である。構造式は次式に示すように、1−3結合したグルコース、1−4結合したグルクロン酸、1−4結合したグルコース、1−4結合したラムノースの繰り返し構造からなる直鎖の高分子多糖である。
The gellan gum in the present invention is U.S. S. A. Developed by Kelco, Inc., which is composed of glucose, glucuronic acid and rhamnose produced by Pseudomonas erodea in a medium mainly composed of glucose (glucose: glucuronic acid: rhamnose = 2: 1: 1). Ratio)), which is mainly composed of heteropolysaccharide. In addition, its molecular weight is about 670,000 to 920,000, and it is an industrial product with high purity that is industrially produced under complete production control. As shown in the following formula, the structural formula is a linear high-molecular polysaccharide composed of repeating 1-3 linked glucose, 1-4 bonded glucuronic acid, 1-4 bonded glucose, and 1-4 bonded rhamnose. is there.
本発明におけるジェランガムの配合量は、外用組成物全体に対して0.001〜1.5質量%が好ましく、特に、同0.005〜1.0質量%が好ましい。外用組成物全体に対して0.001質量%未満の配合量であると、十分にゲル化させることが実質上困難になり、外用組成物全体に対して1.5質量%を超えて配合すると、系に高分子特有の皮膜が形成され、皮膚に適用した際にかえって使用感触が損なわれることになる。 0.001-1.5 mass% is preferable with respect to the whole external composition, and, as for the compounding quantity of the gellan gum in this invention, 0.005-1.0 mass% is especially preferable. When the blending amount is less than 0.001% by mass with respect to the entire external composition, it becomes practically difficult to sufficiently gel, and when it exceeds 1.5% by mass with respect to the entire external composition. A film peculiar to a polymer is formed on the system, and when used on the skin, the feeling of use is impaired.
本発明において用いられる4−メトキシサリチル酸塩の塩の種類としては、製薬学上許容され得る塩であれば、特に限定されるものではなく、例えばナトリウム塩、カリウム塩、カルシウム塩のようなアルカリ金属塩又はアルカリ土類金属塩の他、アンモニウム塩やアミノ酸塩等の塩が挙げられる。なかでも、4−メトキシサリチル酸カリウム塩が、透明度が高く安定性を有するゲルを与える事ができる点で好ましい。本発明においては、4−メトキシサリチル酸塩を配合しても、4−メトキシサリチル酸と塩を形成するアルカリ化合物を別々に配合してもよい。 The kind of 4-methoxysalicylate salt used in the present invention is not particularly limited as long as it is a pharmaceutically acceptable salt. For example, an alkali metal such as sodium salt, potassium salt, calcium salt is used. In addition to salts or alkaline earth metal salts, salts such as ammonium salts and amino acid salts can be mentioned. Of these, potassium 4-methoxysalicylate is preferable in that it can provide a gel having high transparency and stability. In the present invention, 4-methoxysalicylate may be blended or 4-methoxysalicylic acid and an alkali compound that forms a salt may be blended separately.
本発明における4−メトキシサリチル酸塩の配合量は、皮膚外用剤の具体的な剤形や他の配合成分との兼ね合い等に応じて、適宜選択されるべきものであり、特に、限定されるものではないが、外用組成物全体に対して0.001〜10.0質量%であることが好ましく、さらに好ましくは、同0.01〜5.0質量%である。4−メトキシサリチル酸塩の配合量が、外用組成物全体に対して0.001質量%未満では、美白効果を十分発揮させることが困難であり好ましくなく、同10.0質量%を超えて配合しても、配合量の増加に見合った美白効果の向上は認められ難くなり、かえってべたついた使用感を助長する傾向が強く、好ましくない。 The blending amount of 4-methoxysalicylate in the present invention should be appropriately selected according to the specific dosage form of the external preparation for skin and the balance with other blending components, and is particularly limited. Although it is not, it is preferable that it is 0.001-10.0 mass% with respect to the whole external composition, More preferably, it is 0.01-5.0 mass%. When the blending amount of 4-methoxysalicylate is less than 0.001% by mass relative to the entire composition for external use, it is difficult to sufficiently exhibit the whitening effect, and it is blended exceeding 10.0% by mass. However, the improvement of the whitening effect commensurate with the increase in the amount of blending is hardly recognized, and the tendency to promote a rather sticky feeling of use is strong, which is not preferable.
本発明においては、ジェランガムと4−メトキシサリチル酸塩を80〜95℃の高温で溶解した後、ゲルを形成する温度以下に冷却しゲルを作製する。通常、ジェランガムを含む溶液は38℃以下でゲル化するので、好ましくは、15〜38℃、より好ましくは20〜35℃に冷却する。ホモミキサーなどを用いて該ゲルを粉砕して得られた微小ゲル状組成物を化粧料に配合することにより、美白化粧料を提供することが可能となる。
粉砕したゲルを配合する化粧料は、透明液状、半透明液状、O/W乳化系の水相、W/O乳化系の水相のいずれでもよい。また、さらに粉末などが分散した3相系に配合することも可能である。
In this invention, after melt | dissolving gellan gum and 4-methoxy salicylate at high temperature of 80-95 degreeC, it cools below to the temperature which forms a gel, and produces a gel. Usually, since the solution containing gellan gum gels at 38 degrees C or less, Preferably it cools to 15-38 degreeC, More preferably, it is 20-35 degreeC. A whitening cosmetic can be provided by blending the cosmetic with a fine gel composition obtained by pulverizing the gel using a homomixer or the like.
The cosmetic compounded with the pulverized gel may be any of a transparent liquid, a translucent liquid, an O / W emulsified aqueous phase, and a W / O emulsified aqueous phase. It is also possible to blend in a three-phase system in which powders are further dispersed.
ジェランガムと4−メトキシサリチル酸塩を混合したものを加熱溶解せずに、他の化粧料成分を配合しても、液状のままで、適度な粘度の化粧料を得ることができない。
本発明において得られるゲルは、ジェランガムとアスコルビン酸誘導体を用いて作成したゲルよりも、強固なゲルであり、また、高温での安定性が良好で、よりみずみずしくべたつかない特徴を有する。
Even if other cosmetic ingredients are blended without heating and dissolving a mixture of gellan gum and 4-methoxysalicylate, a cosmetic having an appropriate viscosity cannot be obtained.
The gel obtained in the present invention is a stronger gel than a gel prepared using gellan gum and an ascorbic acid derivative, and has a characteristic that it is more stable at high temperatures and more fresh and non-sticky.
本発明において、前記の必須成分に加えて、通常、外用組成物に配合され得る他の成分を、本発明の所期の効果を損なわない限りにおいて配合することができる。
例えば、流動パラフィン、スクワラン、ワセリン等の炭化水素類; マカデミアナッツ油、オリーブ柚、ラノリン等の油脂類;ホホバ油、カルナバロウ、キャンデリラロウ等のロウ類;ジメチルポリシロキサン、メチルフェニルシロキサン等のシリコーン類;カプリルアルコール、ラウリルアルコール、ミリスチルアルコール、セチルアルコール、コレステロール、フィトステロール等の高級アルコール類;カプリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘニン酸、ラノリン脂肪酸、リノール酸、リノレン酸等の高級脂肪酸;ポリエチレングリコール、グリセリン、1,
3-ブチレングリコール、エリスリトール、ソルビトール、キシリトール、マルチトール、ムコ多糖、ヒアルロン酸、コンドロイチン硫酸、キチン、キトサン等の保湿剤;エタノール等の低級アルコール;ブチルヒドロキシトルエン、トコフェロール、フィチン等の酸化防止剤;安息香酸、サリチル酸、ソルビン酸、パラオキシ安息香酸アルキルエステル、ヘキサクロロフェン等の抗菌剤等を適宜配合することができる。
In the present invention, in addition to the essential components described above, other components that can be usually blended in the composition for external use can be blended as long as the desired effects of the present invention are not impaired.
For example, hydrocarbons such as liquid paraffin, squalane and petrolatum; fats and oils such as macadamia nut oil, olive koji and lanolin; waxes such as jojoba oil, carnauba wax and candelilla wax; silicones such as dimethylpolysiloxane and methylphenylsiloxane Higher alcohols such as capryl alcohol, lauryl alcohol, myristyl alcohol, cetyl alcohol, cholesterol, phytosterol; higher fatty acids such as capric acid, myristic acid, palmitic acid, stearic acid, behenic acid, lanolin fatty acid, linoleic acid, linolenic acid; Polyethylene glycol, glycerin, 1,
Moisturizers such as 3-butylene glycol, erythritol, sorbitol, xylitol, maltitol, mucopolysaccharide, hyaluronic acid, chondroitin sulfate, chitin, chitosan; lower alcohols such as ethanol; antioxidants such as butylhydroxytoluene, tocopherol, and phytin; Antibacterial agents such as benzoic acid, salicylic acid, sorbic acid, paraoxybenzoic acid alkyl ester, hexachlorophene, and the like can be appropriately blended.
また、グリシン、アラニン、バリン、ロイシン、トレオニン、フェニルアラニン、チロシン、アスパラギン酸、アスパラギン、グルタミン、タウリン、ヒスチジン等のアミノ酸及びこれらのアルカリ金属塩と塩酸塩;アシルサルコシン酸(例えばラウロイルサルコシンナトリウム)、グルタチオン;クエン酸、リンゴ酸、酒石酸、乳酸等の有機酸;ビタミンA及びその誘導体;ビタミンB6塩酸塩、ビタミンB6トリパルミテート、ビタミンB6ジオクタノエート、ビタミンB2及びその誘導体、ビタミンB12、ビタミンB15及びその誘導体等のビタミンB類;α−トコフェロール、β−トコフェロール、γ−トコフェロール、ビタミンEアセテート等のビタミンE類;ビタミンD類;ビタミンH、パントテン酸、パンテチン等のビタミン類;ニコチン酸アミド、ニコチン酸ベンジル、γ−オリザノール、アラントイン、グリチルリチン酸(塩)、グリチルレチン酸及びその誘導体、ヒノキチオール、ビサボロール、ユーカリプトール、チモール、イノシトール、サイコサポニン、ニンジンサポニン、ヘチマサポニン、ムクロジサポニン等のサポニン類、パントテニルエチルエーテル、エチニルエストラジオール、トラネキサム酸、アルブチン、セファランチン、プラセンタエキス等の各種薬剤;ギシギシ、クララ、コウホネ、オレンジ、セージ、ノコギリソウ、ゼニアオイ、センブリ、タイム、トウキ、トウヒ、バーチ、スギナ、ヘチマ、マロニエ、ユキノシタ、アルニカ、ユリ、ヨモギ、シャクヤク、アロエ、クチナシ、サワラ等の各種の溶媒で抽出した天然エキス;中和剤、酸化防止剤、色素、香料、精製水等を適宜配合することができる。 Amino acids such as glycine, alanine, valine, leucine, threonine, phenylalanine, tyrosine, aspartic acid, asparagine, glutamine, taurine, histidine and their alkali metal salts and hydrochlorides; acyl sarcosine acids (eg, lauroyl sarcosine sodium), glutathione Organic acids such as citric acid, malic acid, tartaric acid and lactic acid; vitamin A and its derivatives; vitamin B6 hydrochloride, vitamin B6 tripalmitate, vitamin B6 dioctanoate, vitamin B2 and its derivatives, vitamin B12, vitamin B15 and its derivatives Vitamin B such as α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E acetate, etc .; vitamin D; vitamins such as vitamin H, pantothenic acid, panthetin, etc. Nicotinamide, benzyl nicotinate, γ-oryzanol, allantoin, glycyrrhizic acid (salt), glycyrrhetinic acid and its derivatives, hinokitiol, bisabolol, eucalyptol, thymol, inositol, saikosaponin, carrot saponin, hetimasaponin, muclodisaponin Various drugs such as saponins such as pantothenyl ethyl ether, ethinyl estradiol, tranexamic acid, arbutin, cephalanthin, and placenta extract; borage, clara, corn, orange, sage, yarrow, zebra, thyme, thyme, spruce, spruce, birch , Natural extracts extracted with various solvents such as horsetail, loofah, maroonier, yukinoshita, arnica, lily, mugwort, peonies, aloe, gardenia, sawara, etc .; neutralizing agent, Antioxidants, pigments, fragrances, purified water and the like can be appropriately blended.
本発明の実施の形態は次の通りである。但し、配合量の単位は質量%である。 The embodiment of the present invention is as follows. However, the unit of the amount is mass%.
実施例1:可溶化系美白化粧液
Aパーツ
エタノール 10.0
PPG−13
デシルテトラデセス−24 0.3
パラオキシ安息香酸メチル 0.1
フェノキシエタノール 0.1
香料 微量
乳酸メンチル 0.004
Bパーツ
グリセリン 2.0
PEG/PPG−14/7ジメチルエーテル 3.0
ジプロピレングリコール 1.0
1,3ブチレングリコール 5.0
ジュウヤク抽出液 0.5
カリン抽出液 0.1
グリチルリチン酸ジカリウム 0.05
精製水 残余
Cパーツ
精製水 52.0
ジェランガム 0.2
4−メトキシサリチル酸カリウム塩 1.0
「製造方法」
Aのアルコール相をBの水相に添加し、可溶化して化粧水を調製した。C相のジェランガムを85℃で溶解し、4−メトキシサリチル酸カリウム塩を加えた後、25℃(室温)に冷却し、固化させたものを粉砕して、前記化粧水に添加した。
Example 1: Solubilized whitening cosmetic liquid A parts ethanol 10.0
PPG-13
Decyltetradeces-24 0.3
Methyl paraoxybenzoate 0.1
Phenoxyethanol 0.1
Fragrance Mentyl lactate 0.004
B parts glycerin 2.0
PEG / PPG-14 / 7 dimethyl ether 3.0
Dipropylene glycol 1.0
1,3 Butylene glycol 5.0
Juyaku extract 0.5
Karin extract 0.1
Dipotassium glycyrrhizinate 0.05
Purified water Residual C parts purified water 52.0
Gellan gum 0.2
4-methoxysalicylic acid potassium salt 1.0
"Production method"
The alcohol phase of A was added to the aqueous phase of B and solubilized to prepare a lotion. Phase C gellan gum was dissolved at 85 ° C., potassium 4-methoxysalicylate was added, cooled to 25 ° C. (room temperature), solidified, crushed, and added to the skin lotion.
実施例2:可溶化系美白化粧液のシート状含侵マスク
「製造方法」
実施例1の化粧液を、さらに不織布に含浸させて、可溶化系美白化粧液含浸シート状マスクを得た。
Example 2: Sheet-like impregnated mask of solubilized whitening cosmetic liquid “Production method”
The cosmetic liquid of Example 1 was further impregnated into a non-woven fabric to obtain a solubilized whitening cosmetic liquid-impregnated sheet-like mask.
実施例3:可溶化系美白化粧液
Aパーツ
エタノール 10.0
PPG−13 デシルテトラデセス−24 0.3
パラオキシ安息香酸メチル 0.1
フェノキシエタノール 0.1
香料 微量
Bパーツ
グリセリン 2.0
PEG/PPG−14/7ジメチルエーテル 3.0
ジプロピレングリコール 1.0
1,3ブチレングリコール 5.0
ブナの芽エキス 0.5
アセンヤクエキス 0.1
ユキノシタエキス 0.1
甘草エキス 0.3
シャクヤクエキス 0.5
オノニスエキス 0.3
ミシマサイコ根エキス 0.1
ばらエキス 0.3
グリチルリチン酸ジカリウム 0.05
精製水 残余
Cパーツ
精製水 56.0
ジェランガム 0.2
4−メトキシサリチル酸カリウム塩 1.0
「製造方法」
Aのアルコール相をBの水相に添加し、可溶化して化粧水を調整した。C相のジェランガムを85℃で溶解し、4−メトキシサリチル酸カリウム塩を加えた後、25℃(室温)に冷却し、固化させたものを粉砕して、化粧水に添加した。
Example 3: Solubilized whitening cosmetic liquid A parts ethanol 10.0
PPG-13 Decyltetradeceth-24 0.3
Methyl paraoxybenzoate 0.1
Phenoxyethanol 0.1
Fragrance Trace B parts Glycerin 2.0
PEG / PPG-14 / 7 dimethyl ether 3.0
Dipropylene glycol 1.0
1,3 Butylene glycol 5.0
Beech bud extract 0.5
Asenya extract 0.1
Yukinoshita Extract 0.1
Licorice extract 0.3
Peonies extract 0.5
ONONIS EXTRACT 0.3
Mishima psycho root extract 0.1
Rose extract 0.3
Dipotassium glycyrrhizinate 0.05
Purified water Residual C parts purified water 56.0
Gellan gum 0.2
4-methoxysalicylic acid potassium salt 1.0
"Production method"
The alcohol phase of A was added to the aqueous phase of B and solubilized to prepare a lotion. Phase C gellan gum was dissolved at 85 ° C. and potassium 4-methoxysalicylate was added, then cooled to 25 ° C. (room temperature), and the solidified product was pulverized and added to the skin lotion.
実施例4:可溶化系美白化粧液のシート状含侵マスク
実施例2の化粧液を、さらに不織布などに含浸させて、可溶化系美白化粧液含浸シート状マスクを得た
Example 4: Sheet-shaped impregnated mask of solubilized whitening cosmetic liquid The cosmetic liquid of Example 2 was further impregnated into a nonwoven fabric or the like to obtain a solubilized whitening cosmetic liquid-impregnated sheet-shaped mask.
実施例5:美白乳液
Aパーツ
ジメチコン 1.0
スクワラン 1.0
エチルヘキサン酸セチル 2.0
カルボキシビニルポリマー 0.2
香料 微量
Bパーツ
グリセリン 2.0
ポリオキシエチレン硬化ヒマシ油 0.3
パラオキシ安息香酸メチル 0.1
フェノキシエタノール 0.1
PEG/PPG−14/7ジメチルエーテル 3.0
ジプロピレングリコール 1.0
1,3ブチレングリコール 5.0
オウバクエキス 0.3
ヒオウギエキス 0.3
ビワエキス 0.5
アロエエキス 0.3
ショウキョウエキス 0.1
グリチルリチン酸ジカリウム 0.05
精製水 残余
苛性カリ 適量
Cパーツ
精製水 52.0
ジェランガム 0.2
4−メトキシサリチル酸カリウム塩 1.0
「製造方法」
Aの油相をBの水相に添加し、乳化した後、C相のジェランガムを85℃で溶解し、4−メトキシサリチル酸カリウム塩を加えた後、25℃(室温)に冷却し、固化させたものを粉砕して、乳液を得た。
Example 5: Whitening Milk A Parts Dimethicone 1.0
Squalane 1.0
Cetyl ethylhexanoate 2.0
Carboxyvinyl polymer 0.2
Fragrance Trace B parts Glycerin 2.0
Polyoxyethylene hydrogenated castor oil 0.3
Methyl paraoxybenzoate 0.1
Phenoxyethanol 0.1
PEG / PPG-14 / 7 dimethyl ether 3.0
Dipropylene glycol 1.0
1,3 Butylene glycol 5.0
Oat extract 0.3
Hinogi extract 0.3
Loquat extract 0.5
Aloe extract 0.3
Ginger extract 0.1
Dipotassium glycyrrhizinate 0.05
Purified water Residual caustic potash appropriate amount C parts purified water 52.0
Gellan gum 0.2
4-methoxysalicylic acid potassium salt 1.0
"Production method"
After the oil phase of A is added to the aqueous phase of B and emulsified, the gellan gum of phase C is dissolved at 85 ° C. and 4-methoxysalicylic acid potassium salt is added, and then cooled to 25 ° C. (room temperature) and solidified. The emulsion was crushed to obtain an emulsion.
実施例6:乳液のシート状含侵マスク
実施例5の乳液を、さらに不織布などに含浸させて、乳液含浸シート状マスクを得た。
Example 6: Emulsion sheet-like impregnated mask The emulsion of Example 5 was further impregnated into a nonwoven fabric or the like to obtain an emulsion-impregnated sheet-like mask.
実施例7:白濁系美白美容液
Aパーツ
ジイソステアリン酸ポリグリセリル 0.2
PEG−60水添ヒマシ油 0.2
トリ2−エチルヘキサン酸グリセリル 0.3
パラオキシ安息香酸メチル 0.17
香料 微量
Bパーツ
グリセリン 3.0
1,3ブチレングリコール 9.5
Cパーツ
苛性カリ 適量
グリチルリチン酸ジカリウム 0.05
ヨモギ抽出液 0.3
ハマメリスエキス 0.1
カミツレ抽出液 0.5
精製水 残余
Dパーツ
精製水 52.0
ジェランガム 0.2
4−メトキシサリチル酸カリウム塩 1.0
「製造方法」
A相をB相と混合してから、Cの水相に添加し、白濁系化粧水を調整した。D相のジェランガムを85℃で溶解し、4−メトキシサリチル酸カリウム塩を加えた後、25℃(室温)に冷却・粉砕したものを、前記白濁系化粧水に加えて、半透明美容液を得た。
Example 7: Whitening whitening serum A parts diglyceryl diisostearate 0.2
PEG-60 hydrogenated castor oil 0.2
Glyceryl tri-2-ethylhexanoate 0.3
Methyl paraoxybenzoate 0.17
Fragrance Trace B parts Glycerin 3.0
1,3 Butylene glycol 9.5
C parts caustic potash appropriate amount dipotassium glycyrrhizinate 0.05
Artemisia extract 0.3
Hamelis Extract 0.1
Chamomile extract 0.5
Purified water Residual D parts purified water 52.0
Gellan gum 0.2
4-methoxysalicylic acid potassium salt 1.0
"Production method"
The A phase was mixed with the B phase and then added to the C aqueous phase to prepare a cloudy lotion. Dissolve D-phase gellan gum at 85 ° C., add 4-methoxysalicylic acid potassium salt, cool and pulverize to 25 ° C. (room temperature), and add to the cloudy lotion to obtain a translucent serum. It was.
実施例8:半透明美白化粧液のシート状含侵マスク
実施例7の化粧液を、さらに不織布などに含浸させて、可溶化系美白化粧液含浸シート状マスクを得た。
Example 8: Sheet-like impregnated mask of translucent whitening cosmetic liquid The cosmetic liquid of Example 7 was further impregnated into a nonwoven fabric or the like to obtain a solubilized whitening cosmetic liquid-impregnated sheet-shaped mask.
実施例9:美白クリーム
Aパーツ
スクワラン 10.0
セタノール 5.0
ワセリン 1.0
エチルヘキサン酸セチル 1.0
トリオクタノイン 2.0
イソステアリン酸PEG−60グリセリル 2.5
ステアリン酸グリセリル 2.8
香料 微量
Bパーツ
グリセリン 2.0
パラオキシ安息香酸メチル 0.1
フェノキシエタノール 0.1
PEG/PPG−14/7ジメチルエーテル 3.0
ジプロピレングリコール 1.0
1,3−ブチレングリコール 5.0
グリチルリチン酸ジカリウム 0.05
精製水 残余
苛性カリ 適量
Cパーツ
精製水 52.0
ジェランガム 0.2
4−メトキシサリチル酸カリウム塩 1.0
「製造方法」
Aの油相をBの水相に添加し、乳化した後、C相のジェランガムを85℃で溶解し、4−メトキシサリチル酸カリウム塩を加えた後、25℃(室温)に冷却し、固化させたものを粉砕して、クリームを得た。
Example 9: Whitening Cream A Parts Squalane 10.0
Cetanol 5.0
Vaseline 1.0
Cetyl ethylhexanoate 1.0
Trioctanoin 2.0
PEG-60 glyceryl isostearate 2.5
Glyceryl stearate 2.8
Fragrance Trace B parts Glycerin 2.0
Methyl paraoxybenzoate 0.1
Phenoxyethanol 0.1
PEG / PPG-14 / 7 dimethyl ether 3.0
Dipropylene glycol 1.0
1,3-butylene glycol 5.0
Dipotassium glycyrrhizinate 0.05
Purified water Residual caustic potash appropriate amount C parts purified water 52.0
Gellan gum 0.2
4-methoxysalicylic acid potassium salt 1.0
"Production method"
After the oil phase of A is added to the aqueous phase of B and emulsified, the gellan gum of phase C is dissolved at 85 ° C. and 4-methoxysalicylic acid potassium salt is added, and then cooled to 25 ° C. (room temperature) and solidified. The cream was crushed to obtain a cream.
比較例1:白濁系美白美容液
実施例7の処方において、A相をB相と混合してから、Cの水相に添加し、得えられた白濁化粧水にD相を溶解して、半透明美容液を得た。(高温溶解なし)
Comparative Example 1: White turbid whitening serum In the formulation of Example 7, A phase was mixed with B phase, then added to C aqueous phase, D phase was dissolved in the obtained cloudy lotion, A translucent serum was obtained. (No hot melt)
「評価」後述の評価基準で、実施例1を評価した結果を示す。 “Evaluation” The results of evaluating Example 1 according to the evaluation criteria described later are shown.
(1)使用性の評価
各化粧料について、5名の専門パネルによる化粧料の使用テストを行い、塗布時のべたつきのなさ・みずみずしさ、使用後のべたつきのなさ・さっぱり感について、以下の評価点の基準に基づいて評価した。
◎:非常に優れる(5名中、4名以上が評価項目について優れると回答)
○:やや優れる(5名中、2〜3名が評価項目について優れると回答)
△:やや劣る(5名中、1名が評価項目について優れると回答)
×:劣る(5名中、0名が評価項目について優れると回答)
(1) Evaluation of Usability For each cosmetic, a cosmetic use test was conducted by five specialist panels, and the following evaluations were made regarding the non-stickiness / freshness at the time of application and the non-stickiness / freshness after use. Evaluation was based on point criteria.
◎: Excellent (4 out of 5 responded that the evaluation items were excellent)
○: Slightly superior (2 to 3 out of 5 responded that the evaluation items were excellent)
Δ: Slightly inferior (1 out of 5 responded that the evaluation item was superior)
X: Inferior (out of 5 respondents said that 0 are superior in terms of evaluation items)
(2)粘度の評価
ビスメトロン粘度計VDA(芝浦システム株式会社製)を用いて試作直後の粘度(室温)を測定し評価した。
◎:かなり粘度がある(5000mPa・sを超える)
○:粘度がある(500mPa・s〜5000mPa・s)
△:やや粘度がある(50mPa・s〜500mPa・s)
×:粘度がない(50mPa・s未満)
(2) Evaluation of viscosity
The viscosity (room temperature) immediately after trial production was measured and evaluated using a bismetholone viscometer VDA (manufactured by Shibaura System Co., Ltd.)
A: Very viscous (exceeds 5000 mPa · s)
○: Viscosity (500 mPa · s to 5000 mPa · s)
Δ: Some viscosity (50 mPa · s to 500 mPa · s)
×: No viscosity (less than 50 mPa · s)
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007070025A JP2008230994A (en) | 2007-03-19 | 2007-03-19 | Cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007070025A JP2008230994A (en) | 2007-03-19 | 2007-03-19 | Cosmetic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2008230994A true JP2008230994A (en) | 2008-10-02 |
Family
ID=39904233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007070025A Withdrawn JP2008230994A (en) | 2007-03-19 | 2007-03-19 | Cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2008230994A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011077779A1 (en) * | 2009-12-21 | 2011-06-30 | 株式会社資生堂 | Sheet-like cosmetic |
| CN110302136A (en) * | 2019-08-13 | 2019-10-08 | 西安博和医疗科技有限公司 | Whitening and skin-protecting composition |
| CN110448518A (en) * | 2019-08-21 | 2019-11-15 | 西安博和医疗科技有限公司 | A kind of preparation method of whitening body lotion |
| JP7458639B2 (en) | 2020-11-02 | 2024-04-01 | シヤチハタ株式会社 | Flavor composition for stamp pads, vermilion stamps or penetrating stamps |
-
2007
- 2007-03-19 JP JP2007070025A patent/JP2008230994A/en not_active Withdrawn
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011077779A1 (en) * | 2009-12-21 | 2011-06-30 | 株式会社資生堂 | Sheet-like cosmetic |
| JP2011126844A (en) * | 2009-12-21 | 2011-06-30 | Shiseido Co Ltd | Cosmetic sheet product |
| CN102470086A (en) * | 2009-12-21 | 2012-05-23 | 株式会社资生堂 | Sheet-like cosmetic |
| KR101157939B1 (en) * | 2009-12-21 | 2012-06-22 | 가부시키가이샤 시세이도 | Sheet-like cosmetic |
| RU2474412C1 (en) * | 2009-12-21 | 2013-02-10 | Шисейдо Компани, Лтд. | Cosmetic product as sheet-like material |
| US8524263B2 (en) | 2009-12-21 | 2013-09-03 | Shiseido Company, Ltd. | Sheet-like cosmetic |
| CN102470086B (en) * | 2009-12-21 | 2014-04-30 | 株式会社资生堂 | Sheet-like cosmetic |
| EP2444058A4 (en) * | 2009-12-21 | 2015-01-07 | Shiseido Co Ltd | COSMETIC PRODUCT OF THE SHEET TYPE |
| TWI480056B (en) * | 2009-12-21 | 2015-04-11 | Shiseido Co Ltd | Flake Cosmetics |
| AU2010334096B2 (en) * | 2009-12-21 | 2015-10-08 | Shiseido Company, Ltd. | Sheet-like cosmetic |
| CN110302136A (en) * | 2019-08-13 | 2019-10-08 | 西安博和医疗科技有限公司 | Whitening and skin-protecting composition |
| CN110448518A (en) * | 2019-08-21 | 2019-11-15 | 西安博和医疗科技有限公司 | A kind of preparation method of whitening body lotion |
| JP7458639B2 (en) | 2020-11-02 | 2024-04-01 | シヤチハタ株式会社 | Flavor composition for stamp pads, vermilion stamps or penetrating stamps |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2387985B1 (en) | Process for producing o/w microemulsion preparation for external application | |
| CN102596151B (en) | Method for producing O/W emulsion composition | |
| EP2474297A1 (en) | Method for producing o/w cream having high viscosity | |
| JP2021098655A (en) | Skin external composition | |
| JP4643377B2 (en) | One-phase microemulsion composition and method for producing O / W ultrafine emulsion external preparation | |
| JP2009242326A (en) | Skin-lightening liquid cosmetic | |
| JP2008230994A (en) | Cosmetic | |
| JP4762495B2 (en) | Method for producing O / W ultra fine emulsion external preparation | |
| JP5840838B2 (en) | Thickening composition and method for producing the same | |
| KR20000022959A (en) | External application composition | |
| JP2008230995A (en) | Cosmetic | |
| JP3559688B2 (en) | Cosmetics | |
| JP2005132828A (en) | Composition for external application | |
| JP2008100937A (en) | O/w type finely emulsified preparation for external use and method for producing the same | |
| JP5117208B2 (en) | Highly polar oil-containing oil-in-water ultrafine emulsion external preparation and method for producing the oil-in-water ultrafine emulsion external preparation | |
| JPWO2020066895A1 (en) | Composition for skin cosmetics | |
| JP4370595B2 (en) | Gel composition, fragrance, external preparation for skin and cosmetics | |
| JP2000143436A (en) | Composition for external use | |
| JP2009242281A (en) | External preparation comprising ultrafine oil-in-water emulsion comprising high-polarity oil and production method thereof | |
| JP3641366B2 (en) | Topical skin preparation | |
| JP4275872B2 (en) | Mixing topical skin composition for use | |
| JP5235261B2 (en) | Method for producing translucent cosmetics | |
| JPH09124437A (en) | Emulsified composition and dermal preparation for external use | |
| CN100428923C (en) | External composition | |
| JP2012254957A (en) | External skin preparation and production method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20100601 |